NEW YORK (GenomeWeb News) — Applied Biosystems today reported that fiscal first-quarter revenues rose 5 percent as R&D spending swelled 12 percent and a loss swung to a profit.

Separately today, the company announced the “worldwide commercial availability” of its SOLiD next-generation sequencer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.